Akari Therapeutics Appoints Former AACR President and Renowned Oncology Drug Development Leader, Patricia LoRusso, D.O., to Scientific Advisory Board
Akari Therapeutics appointed Dr. Patricia LoRusso, a globally recognized oncology drug development expert and former AACR President, to its Scientific Advisory Board. This strategic addition comes as Akari advances its lead antibody drug conjugate candidate AKTX-101—featuring a novel RNA splicing modulator payload—toward a Phase 1 First-in-Human cl…